| ($ in millions, except per share) | Q4 2025 | Q4 2024 | YoY Change | FY 2025 | |
|---|---|---|---|---|---|
| Total Revenue | $24,820 | $22,900 | +8.4% | $94,150 | |
| Cost of Revenue | $(14,380) | $(13,520) | +6.3% | $(56,420) | |
| Gross Profit | $10,440 | $9,380 | +11.3% | $37,730 | |
| Gross Margin % | 42.1% | 40.9% | +120 bps | 40.1% | |
| Operating Expenses | $(5,210) | $(4,980) | +4.6% | $(20,150) | |
| Operating Income | $5,230 | $4,400 | +18.9% | $17,580 | |
| Net Income | $3,210 | $2,860 | +12.1% | $11,940 | |
| EPS (Diluted) | $4.12 | $3.60 | +14.3% | $15.38 |
"We delivered $4.05 billion in free cash flow for the quarter, up 9.7% year-over-year, reinforcing our commitment to shareholder returns. The board has approved a 6.2% dividend increase and authorized an additional $3 billion in share repurchases for FY 2026. Our balance sheet remains fortress-strong with an investment-grade rating and net leverage below 1.8x."— Marcus Chen, Chief Financial Officer
Based on current market conditions and pipeline visibility, Aevum Zenth provides the following preliminary guidance for Fiscal Year 2026:
Forward-Looking Statements: This report contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. These statements are based on current expectations and assumptions that are subject to risks and uncertainties. Actual results may differ materially due to factors including but not limited to macroeconomic conditions, regulatory changes, supply chain disruptions, technological adoption rates, and geopolitical events. Aevum Zenth undertakes no obligation to update these statements except as required by law. For a detailed discussion of risk factors, please refer to Part I, Item 1A of our Annual Report on Form 10-K.
For investor inquiries, contact: investors@aevumzenth.com | +1 (888) 555-0192